Has CYDY given a reason for the delay? I haven't had the

New Post Public Reply Private Reply Replies (0) Message Board
nothingspecial ohm20 #109582
645
Has CYDY given a reason for the delay? I haven't had the time to follow closely.
IMHO, even though LH trial seems like a slam dunk where p-values are concerned, I find it comforting that the company is taking it's time with this particular indication as getting doctors to prescribe it & insurance companies to pay for it may prove to be tricky given all the symptoms & similarities.
I suspect that they will be running 2 trials simultaneously. One for approval & another for their data bank
To be able to say conclusively who it helps & how to know, plus dosage amounts & frequency would pretty much make CYDY " King of the World!"
Not to mention how valuable the data would be for other indications in helping assure more efficient & ultimately successful trials.
At this juncture, they absolutely must get this one right for the sake of the long haul( pun intended).
I would like to share a little conjecture & I am sure you can tell me if it is credible at all where science is concerned. I honestly do not have a clue.TIA.
Personally I would not want to start LH trial immediately. It is most important that trial is controlled & monitored to the highest level. The data needs to show consistency & continuity.
So here we are looking at Thanksgiving, Christmas & New Years' Eve. Never mind the stress, anxiety & pressure. Do not dwell on logistics nightmares like individual travel & delivery of product or overworked staff that would like to be elsewhere. No I am talking about office parties, 2 day drunks(workers & patients), family get togethers with extra desert, erratic sleep & bowel movements. Alcohol (other stuff) sweets,grease, time off, spreader events(colds flu as well), fatigue, winter doldrums,etc...
Come January people traditionally seek to do better, the days start getting longer, the other crap is behind you & you are too broke to do more damage.
Thoughts?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Drone Technology Transforms Automotive Security Landscape

Updated Category News Views 203

Revolutionizing Security with Drone Technology Titan Protection and Consulting recently heralded a significant achievement in the field of security technology. The company has introduced a pioneering deployment of self-docking, remote-piloted security drones, which successfully thwarted an attempted theft at a dealership in Kansas City. This event not only underscores...

Continue Reading
Cost of Living Tops Financial Worries in 2026

Updated Category News Views 13

Financial Stress — The Silent Productivity Killer Down in the trenches of nine-to-five, it’s money that keeps stealing workers' peace of mind. The TELUS Mental Health Index shines a glaring spotlight on this, revealing that 58% of U.S. workers are most stressed by living costs. Now, that's a kicker when stacking it next to retirement or emergency savings. Those take...

Continue Reading
Equinor Achieves Significant Oil Discovery Near Troll Field

Updated Category News Views 1323

Equinor Makes a New Oil Discovery in the North Sea Equinor ASA (NYSE: EQNR) is experiencing a positive surge in its stock prices today, following the recent discovery of a new oil field located 17 kilometers from the Troll field in the North Sea. This exciting discovery has estimated reserves that could range between 2 and 12 million barrels of oil equivalent, which...

Continue Reading
Xact Labs' Patent Boosts Precision Medicine Impact

Updated Category News Views 7

Game-Changing Patent for Xact Labs Xact Laboratories just nabbed a new patent—number 12,640,242 if you're keeping track. This isn't just a shiny badge for show; it's core to their play in the big leagues of precision medicine, clinching their spot as a frontrunner in genetic data integration. The endgame here? Tighten that grip on the precision medicine field, and turn...

Continue Reading
Insightful Options Activity Around Cleveland-Cliffs Revealed

Updated Category News Views 178

Understanding Cleveland-Cliffs' Options Activity Recently, significant investments have been noted in Cleveland-Cliffs, indicating a bullish sentiment among traders. Investors are closely analyzing the options activity for Cleveland-Cliffs (NYSE: CLF), which has revealed a series of intriguing trades. An Overview of Recent Trades Upon reviewing recent options transactions...

Continue Reading